You are here: Industry Insights > NCATS

News List

Speeding new treatments worldpharmanews
May 11, 2021
A year into the COVID-19 pandemic, mass vaccinations have begun to raise the tantalizing prospect of herd immunity that eventually curtails or halts the spread of SARS-CoV-2. But what if herd immunity is never fully achieved - or if the mutating virus ...
NIH scientists identify small-molecule cocktail to prevent cellular stress pharmaceutical-technology
May 06, 2021
The US National Institutes of Health (NIH) scientists have identified a four-part small-molecule cocktail that can provide protection to induced pluripotent stem cells (iPSCs) from stress and preserve regular stem cell structure and function.
Sound Pharmaceuticals Receives $3.1M NIH Grant for COVID Treatment contractpharma
April 08, 2021
Sound Pharmaceuticals, Inc. (SPI) has received a Cooperative Grant award from the National Center for Advancing Translational Sciences (NCATS) at the NIH for $3.1 milion to support the testing of SPI-1005 in two Phase 2 clinical trials for the ...
Acer Therapeutics, NCATS partner to develop emetine for Covid-19 pharmaceutical-technology
May 14, 2020
Pharmaceutical company Acer Therapeutics has partnered with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride for the potential treatment of Covid-19 patients.
FDA launches app for health care professionals worldpharmanews
December 10, 2019
The U.S. Food and Drug Administration announced the global launch of CURE ID, an internet-based repository that will allow the clinical community to report their experiences ...